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Purpose: To investigate the methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C genotypes and plasma
concentrations of total homocysteine (tHcy) in Pakistani patients with primary open angle glaucoma (POAG) and primary
closed angle glaucoma (PCAG).
Methods: This was a prospective case-control study. A total of 295 patients (173 POAG, 122 PCAG) and 143 age- and
sex-matched controls were subdivided into two ethnic groups, Punjabis (Punjab province, central Pakistan) and Pathans
(North-West Frontier Province, northern Pakistan). Genotypes of the MTHFR C677T and A1298C polymorphisms were
detected by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP). An enzyme-linked
immunosorbent assay was used to determine the total serum homocysteine (tHcy) levels. Associations were determined
by logistic regression analysis.
Results: Frequency distributions of genotypes and combined genotypes as well as homocysteine levels were obtained.
The overall distribution of the C677T genotype was found to be significantly associated with PCAG (CC 69%, CT 21%,
TT 10%; p=0.001, χ2=12.6), but not with POAG (CC 71%, CT 28%, TT 1%; p=0.98, χ2=0.02) as compared to the controls
(CC 71%, CT 29%, TT 1%). The Pathan cohorts revealed no association with the disease; however, the Punjabis
demonstrated a significant association with PCAG (CC 75%, CT 11%, TT 13%; p<0.001, χ2=17.2). PCAG in the Punjabi
subjects was also significantly associated with the A1298C polymorphism (AA 43%, AC 54%, CC 3%; p<0.001, χ2=33.9)
as compared to the controls. Combined genotype data showed no association with POAG; however, a significant
association with all combined genotypes was observed in the overall PCAG subjects (p<0.05, χ2=20.1). This difference
was particularly apparent in the TTAA and TTAC combinations that were completely absent in the control groups (p<0.05.
χ2=49.6). Mean serum tHcy levels were found to be significantly increased in the POAG (15.2±1.28 µmol/l, p<0.001) and
PCAG (20.8±4.8 µmol/l) groups as compared to the controls (10.0±0.97 µmol/l). The tHcy levels in the TT and AC
genotype were significantly elevated in the PCAG group (67±12.39 µmol/l, p<0.001; 23±5.94 µmol/l, p=0.027) as
compared to the controls.
Conclusion: The TT and AC genotypes of MTHFR C677T and A1298C polymorphisms and the combined genotype
TTAC were associated with PCAG in Punjabi subjects of Pakistani origin and correlated with the high serum tHcy levels
seen in these patients.
The methylenetetrahydrofolate reductase (MTHFR)
enzyme catalyzes the reduction of 5,10-
methylenetetrahydrofolate to 5-methyltetrahydrofolate, the
methyl donor for the conversion of homocysteine to
methionine [1]. Genetic polymorphisms in the MTHFR gene
are well established, the most extensively studied of which are
C677T and A1298C single-nucleotide polymorphisms
(SNPs). The C677T SNP results in a missense mutation
leading to the substitution of valine for alanine at position 222
of the MTHFR enzyme, causing the synthesis of a
thermolabile enzyme with a 50% reduction in activity [2-4].
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The other SNP, A1298C, which is located within the COOH-
terminal regulatory domain of the MTHFR, results in the
substitution of glutamate for an alanine residue [5,6] and has
also been associated with a mild reduction in enzymatic
activity [7]. Reduced MTHFR enzyme activity is
subsequently followed by increases in circulating
homocysteine levels (hyperhomocysteinemia) [8].
Glaucoma is an optic neuropathy that results in
progressive damage to the visual field. It is one of the leading
causes of irreversible blindness in the world [9]. The two
common types of glaucoma include primary open angle
glaucoma (POAG) and primary closed angle glaucoma
(PCAG). To date there are conflicting results regarding the
association of MTHFR polymorphisms with glaucoma.
Several studies have reported an association of the C677T
polymorphism with glaucoma [10-13], whereas in other
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studies, particularly in European populations, this
polymorphism appears to play no role in the development of
glaucoma [14-17]. The relationship between the A1298C
polymorphism and glaucoma has been studied in Korean
[13], Swedish [14], and Japanese [15] populations, where no
association has been found between the polymorphism and
glaucoma.
Hyperhomocysteinemia has been observed in patients
with glaucoma [17-19]. Bleich and coworkers [19] found
raised plasma homocysteine levels in Caucasian glaucoma
patients with the C677T polymorphism. Reports from various
countries have revealed high levels of homocysteine in the
aqueous humor and the serum of patients suffering from
glaucoma and other ocular diseases [17,20-22].
Hyperhomocysteinemia can induce vascular injuries [23],
alterations in the extracellular matrix [24], and neuronal cell
death [25,26].
We recently reported a significant association of
MTHFR C677T polymorphism with PCAG in the Pakistani
population, but did not find a significant association of this
mutation with POAG [27]. In the present study, we have
further investigated the C677T and A1298C genotypes in
POAG and PCAG in cohorts of Pakistanis, including two
different ethnic groups (Pathans and Punjabis). We have also
analyzed any possible association of genotypes and combined
genotypes with serum homocysteine levels.
METHODS
Patient selection criteria: Approval for the study was
obtained from the Institutional Review Board/Ethics
Committee. All the patients were recruited from the eye
clinics of two different eye hospitals: the Christian Hospital
in Taxila and Al-Shifa Trust Eye Hospital in Rawalpindi.
Patients from the former hospital belonged to the Pathan
ethnic group (from the North-West Frontier Province, located
in the north of Pakistan), whereas from the latter the patients
were Punjabi in ethnicity (from the Punjab province, located
in central Pakistan). The selection criteria, the clinical tests
conducted on the patients and controls, as well as the
collection and processing of whole blood were the same as
described previously [28]. Peripheral blood samples were
obtained from patient and control groups and collected into
EDTA tubes. Immediately after collection, whole blood was
stored in aliquots at -20 °C until use. Informed consent was
obtained from glaucoma patients and normal volunteers.
Blood was obtained from a total of 295 glaucoma subjects
comprising 173 patients with POAG and 122 patients with
PCAG, and 143 control blood samples were also collected and
processed. The POAG patients had a mean age of 50.4±1.1
years (60% males and 40% females), PCAG patients had a
mean age of 52.4±1.5 years (males: 59%, females 41%) and
control subjects had a mean age of 49.1±1.3 years (males:
72%, females 28%). There was no statistically significant
difference between the mean age of POAG and control
subjects (p=0.44) or the distribution of gender in the two
groups (p=0.07). Similarly, there was no statistically
significant difference in the mean age of PCAG and control
subjects (p=0.09) or in the gender distribution of the two
groups (p=0.053).
Polymerase chain reaction–restriction fragment length
polymorphism (PCR-RFLP): The C677T MTHFR
polymorphism was genotyped as previously described [27].
Briefly, we used the forward primer 5'-CCT TGA ACA GGT
GGA GGC CAG-3' and the reverse primer 5'-GCG GTG
AGA GTG GGG TGG AG-3'. The mixture was denatured at
95 °C for 10 min, and the PCR reaction was performed for 35
cycles under the following conditions: denaturation at 95 °C
for 1 min, annealing at 65 °C for 30 s, and extension at 72 °C
for 1 min and a final extension cycle of 72 °C was for 7 min.
PCR products were digested with HinfI (Fermentas, Glen
Burnie, MD) and analyzed on agarose gel (3%). A single
fragment of 294 base pairs (bp) was identified as homozygous
(CC); three fragments of 294, 168, and 126 bp were identified
as heterozygous (CT); and two fragments of 168 and 126 bp
were identified as homozygous (TT) genotype. The A1298C
MTHFR polymorphism was genotyped with the help of the
polymerase chain reaction (PCR) followed by digestion of the
amplified product with the MboII restriction enzyme
(Fermentas). Briefly, for PCR, the forward primer 5′-CTT
TGG GGA GCT GAA GGA CTA CTA-3′ and the reverse
primer 5′-CAC TTT GTG ACC ATT CCG GTT TG-3′ were
used to amplify a 163-base pair (bp) fragment of the
MTHFR gene. The PCR reactions were performed in a 25 μl
reaction mixture containing 1× Taq Buffer (10 mM Tris-HCl,
pH 9.0, 50 mM KCl, 0.1% Triton X-100, 0.01% [w/v] gelatin,
1.5 mM MgCl2; Fermentas), 30 pmol of each primer, 0.2 mM
of the deoxynucleoside triphosphates, 1 U of Taq DNA
polymerase (Fermentas), and 100 ng of genomic DNA
template. The thermal profile used for the PCR amplification
was the same as reported earlier for the C677T amplification
except that the annealing temperature was 62 °C for 30 s. To
confirm the presence of the amplicon of correct size, the PCR
products were electrophoresed on 2% agarose gels (Invitrogen
Corporation, Carlsbad, CA). The amplified products were
then digested with the MboII restriction enzyme as per the
manufacturer’s instructions. After digestion, all the fragments
were resolved on 4% agarose gels. The homozygous normal
allele (AA) produced 5 fragments of 56, 31, 30, 28, and 18 bp
size, the heterozygous (AC) produced 3 fragments of 84, 56,
and 30 bp, whereas the homozygous mutant (CC) produced 4
fragments of 84, 31, 30, and 18 bp.
Total plasma homocysteine determination: Fasting blood
samples of both the patients and control subjects were
collected in plain vacutainers (Becton Dickinson, Lahore,
Pakistan); the plasma was separated with the help of
centrifugation and stored at -35 °C until further analysis. Total
plasma homocysteine was measured using a microplate
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enzyme immunoassay (DRG Diagnostics, Frauenbergstrasse,
Germany).
Statistical analysis: A logistic regression and multivariate
analysis was performed using Statistical Package for the
Social Sciences (SPSS) 16.0 for Windows (SPSS version
16.0, Chicago, IL). The POAG, PCAG, and control data were
compared using the χ2 test and Fisher’s exact test. The
criterion for statistical significance was p<0.05.
RESULTS
MTHFR C677T and A1298C genotype analysis: The
distribution of C677T and A1298C genotypes among the
controls and the patients did not deviate from those predicted
by the Hardy–Weinberg equilibrium. The distribution of the
MTHFR C677T genotype is shown in Table 1. The collective
data of both ethnic groups revealed that the CC genotype was
present at almost the same frequency in the three groups, i.e.
71% in controls and POAG samples and 69% in the PCAG
group. Similarly, the CT genotype was also present within a
statistically non-significant range, i.e. controls=29%,
POAG=28%, and PCAG=21%. However, a statistically
significant difference (p<0.05, χ2=11.8) was observed in the
distribution of the TT genotype between the controls (1%) and
the PCAG group (10%), with statistical analysis of the overall
comparison of the genotypes also being significantly different
(p<0.05, χ2=12.6). There was no difference between the
controls and POAG group. When the data for both the ethnic
groups was analyzed separately, the genotypic distribution in
the Pathan patient groups (POAG & PCAG) was not
significantly different from the Pathan control samples (Table
1). However, the Punjabi PCAG samples were not only
significantly different from the Punjabi control samples in the
overall genotype distribution pattern (p<0.05, χ2=17.2), but
also demonstrated a statistically significant higher frequency
of the mutant TT allele (p<0.05, χ2=10.2) and a significantly
lower distribution of the CT allele (p<0.05, χ2=9.5) than the
controls.
When the genotypic data of the MTHFR A1298C
polymorphism was studied in the collective dataset (Table 2),
a significant difference was found between the overall
distribution of the genotype frequencies of PCAG and
controls (p<0.05, χ2=9.7), with a significantly lower
frequency of the mutant CC genotype in the PCAG group as
compared to the controls (p<0.05, χ2=3.73) as well as a higher
frequency of the AA normal genotype in the PCAG group
when compared to the controls (p≤0.05, χ2=3.7). However,
when the dataset was split up along the lines of ethnicity, the
Pathans did not demonstrate any significant distribution in the
PCAG and POAG groups when compared to the relevant
controls. Contrarily, the Punjabis showed a significant
difference, not only in the overall distribution of the genotypes
(p<0.05, χ2=33.9), but also in the distribution of the different
genotypes: the wild type AA allele being present at a higher
frequency in the PCAG group (43%) as compared to the
controls (4%), and the heterozygous AC and mutant CC
alleles being present at lower frequencies (54% and 3%,
respectively) as compared to the controls (73% and 23%,
respectively).
MTHFR C677T:A1298C combined genotype analysis:
Combined genotypes of the C677T and A1298C
polymorphisms of the MTHFR gene were also obtained for
the collective data of both populations, as well as for the
Pathans and Punjabis separately (Table 3 and Table 4). In the
case of POAG, no statistically significant difference was
observed when the collective data (p=0.83, χ2=2.8) were
analyzed or when the ethnic groups were considered
separately (Pathan: p=0.31, χ2=7.1, Punjabi: p=0.71, χ2=3.7;
Table 3). However, when the combined genotype data of the
PCAG samples were analyzed, a significant difference was
observed for the collective samples (p<0.05, χ2=20.1),
particularly for the samples containing the TT alleles (p<0.05,
χ2=6.9; Table 4), and this was true for the TTAA as well as
the TTAC genotypes (p<0.05, χ2=5.9, p<0.05, χ2=5.7,
respectively).
When the combined genotypes of the ethnic groups were
considered separately, in the Pathans no statistically
significant difference was observed in the overall distribution
of the alleles when compared with the controls, as well as in
the case of any of the combined genotypes (Table 4). As
opposed to this, when the overall data of the PCAG Punjabi
samples were compared with the controls (Table 4), there was
a significant difference in the distribution patterns of the
combined genotypes (p<0.05, χ2=49.6), with almost all the
genotypes showing a difference in the affected individuals
compared with the controls. Both TTAA and TTAC, which
were present at a frequency of 7% in the PCAG group, were
absent in the controls (p<0.05, χ2=4.6). The CCAA combined
genotype was also found to be present at a higher frequency
in the Punjabi PCAG group (28%) as compared to the controls
(4%), which was statistically significant (p<0.05, χ2=14.8).
The same was the case for CTAA (PCAG=8%, controls=0%,
p<0.05, χ2=6.2). But the CCCC and CTCC genotypes were
present at a lower frequency in the affected individuals (3%
and 0%, respectively) as compared to the controls (17% and
7%, respectively), which was also statistically significant
(p<0.05, χ2=6.2 and p<0.05, χ2=4.3, respectively).
MTHFR gene polymorphism and homocysteine
concentrations: The associations of different genotypes with
levels of tHcy were determined in a subgroup of the controls,
POAG, and PCAG patients that were age- and gender
matched. As shown in Figure 1, the mean value of tHcy in the
POAG (15.2±1.28 µmol/l) and PCAG (20.8±4.8 µmol/l)
patients was found to be significantly higher than in the
controls (10.0±0.97 µmol/l). When tHcy levels were
compared across different genotypes in the controls, in the
case of the C677T polymorphism it was found that, compared
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with the normal CC genotype, the TT genotype had
significantly (p<0.001) elevated tHcy levels in the controls
(22 µmol/l±0.0 µmol/l) as well as in the POAG (32 µmol/l
±0.0 µmol/l) and PCAG (67 µmol/l±12.39 µmol/l) groups
(Figure 2). In addition, when the A1298C MTHFR genotypes
were compared, both the PCAG (23±5.94 µmol/l, p<0.027)
and POAG (16±1.51 µmol/l, p<0.001) groups were found to
have significantly elevated levels of tHcy in the AC genotype
as compared to the controls (12±1.25 µmol/l; Figure 2). When
the levels of tHcy were compared against the combined
genotypes, the TTAC had significantly elevated levels (67
µmol/l±12.4 µmol/l; p<0.001), whereas the rest of the
combined genotypes had comparable levels of tHcy between
the controls and the POAG and PCAG patients. Based upon
the Wilks’ lambda, the multivariate analysis of variance
analysis indicates that the tHcy levels differed significantly
across the three groups (i.e. controls, POAG, and PCAG) with
respect to the C677T (F=9.985, p=<0.001), but not the
A1298C (F=2.543, p=0.098) genotype.
Figure 1. Mean plasma homocysteine levels in controls, POAG, and
PCAG subjects. Error bars indicate standard error of the mean.
TABLE 3. COMBINED GENOTYPE ANALYSIS OF METHYLTETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM WITH PRIMARY OPEN ANGLE GLAUCOMA AND CONTROLS.
Combined Subjects
C677T A1298C Controls (143) POAG (173) OR (95%CI) p (χ2) p (χ2)
CC AA 14 (10%) 25 (14%) 0.64 (0.32-1.28) 0.32 (2.2) 0.83 (2.8)
CC AC 66 (46%) 79 (46%) 1.02 (0.65-1.59)
CC CC 21 (15%) 19 (11%) 1.39 (0.72-2.69)
CT AA 6 (4%) 10 (6%) 0.71 (0.26-1.94) 0.76 (0.54)
CT AC 30 (21%) 34 (20%) 1.08 (0.63-1.87)
CT CC 5 (3%) 5 (3%) 1.22 (0.37-4.01)
TT AA 0 (0%) 0 (0%) -------- 0.51 (1.3)
TT AC 1 (1%) 1 (1%) 1.21 (0.12-11.70)
TT CC 0 (0%) 0 (0%) -------
Subjects of Pathan Ethnicity
C677T A1298C Controls (70) POAG (96) OR (95%CI) p (χ2) p (χ2)
CC AA 11 (16%) 21 (22%) 0.67 (0.30-1.47) 0.09 (4.6) 0.31 (7.1)
CC AC 33 (47%) 45 (47%) 1.01 (0.55-1.87)
CC CC 9 (13%) 4 (4%) 3.39 (1.05-10.85)
CT AA 6 (9%) 8 (8%) 1.03 (0.36-2.99) 0.68 (0.76)
CT AC 10 (14%) 17 (18%) 0.77 (0.34-1.79)
CT CC 0 1 (1%) 0.00 (0.00-5.29)
TT AA 0 0 -------- N/A
TT AC 1(1%) 0 --------
TT CC 0 0 --------
Subjects of Punjabi Ethnicity
C677T A1298C Controls (73) POAG (77) OR (95%CI) p (χ2) p (χ2)
CC AA 3 (4%) 4 (5%) 0.78 (0.19-3.25) 0.88 (0.24) 0.71 (3.7)
CC AC 33 (45%) 34 (44%) 1.04 (0.55-1.98)
CC CC 12 (17%) 15 (20%) 0.81 (0.36-1.85)
CT AA 0 2 (3%) 0.00 (0.00-2.02) 0.32 (2.2)
CT AC 20 (27%) 17 (22%) 1.33 (0.64-2.79)
CT CC 5 (7%) 4 (5%) 1.34 (0.37-4.82)
TT AA 0 0  N/A
TT AC 0 1 (1%)  
TT CC 0 0  
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DISCUSSION
SNPs of the MTHFR gene have been shown to be associated
with mild hyperhomocysteinemia. Bleich et al. [19] were the
first to demonstrate an association between increased plasma
homocysteine levels and POAG, which suggested evidence of
its involvement in the pathogenesis of glaucomatous optic
neuropathy. Subsequently, Altintas et al. [29] also
demonstrated that elevation in the levels of tHcy is also
associated with pseudoexfoliative glaucoma. We report here
a markedly increased level of serum tHcy in Pakistani PCAG
patients as compared to POAG patients and controls. To the
best of our knowledge, this is the first study to show an
association of hyperhomocysteinemia with PCAG. We have
previously observed PCAG to be associated with the
MTHFR C677T polymorphism in a Pakistani cohort [27];
however, at that time we did not study the A1298C
polymorphism or the combined genotype frequency
distributions of the two polymorphisms. Our previous study
included patients and controls from a mixed population of
Punjabis (from the Punjab province in central Pakistan) and
Pathans (from the N.W.F.P. province in the north of Pakistan).
In this study, we also investigated any correlation of the
disease with the ethnic origin of the patients being studied.
Consistent with our previous report [27], we found no
association of the MTHFR C677T genotype with POAG but
Figure 2. Mean plasma homocysteine levels in C677T and A1298C
genotypes in controls, POAG, and PCAG samples. Error bars
indicate standard error of the mean.
TABLE 4. COMBINE GENOYPE ANALYSIS OF METHYLTETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM WITH PRIMARY CLOSED ANGLE GLAUCOMA AND CONTROLS.
Combined Subjects
C677T A1298C Controls (143) PCAG (122) OR (95%CI) p (χ2) p (χ2)
CC AA 14 (10%) 22 (18%) 0.49 (0.24-1.00) 0.05 (5.8) 0.005 (20.1)
CC AC 66 (46%) 52 (43%) 1.15 (0.71-1.87)
CC CC 21 (15%) 10 (8%) 1.93 (0.88-4.20)
CT AA 6 (4%) 7 (6%) 1.72 (0.25-2.10) 0.43 (1.7)
CT AC 30 (21%) 17 (14%) 1.64 (0.86-3.12)
CT CC 5 (3%) 2 (2%) 2.17 (0.48-9.87)
TT AA 0 (0%) 5 (4%) 0.00 (0.00-0.63) 0.03 (6.9)
TT AC 1 (1%) 7 (6%) 0.12 (0.02-0.74)
TT CC 0* (0%) 0 (0%) --------
Subjects of Pathan Ethnicity
C677T A1298C Controls (70) PCAG (61) OR (95%CI) p (χ2) p (χ2)
CC AA 11 (16%) 5 (8%) 2.09 (0.71-6.12) 0.62 (0.97) 0.19 (9.8)
CC AC 33 (47%) 25 (41%) 1.28 (0.64-2.56)
CC CC 9 (13%) 8 (13%) 0.98 (0.36-2.64)
CT AA 6 (9%) 2 (3%) 2.77 (0.61-12.41) 0.09 (4.8)
CT AC 10 (14%) 15 (25%) 0.51 (0.21-1.23)
CT CC 0 2 (3%) 0.00 (0.00-1.67)
TT AA 0 1 (2%) 0.00 (0.00-3.58) N/A
TT AC 1 (1%) 3 (5%) 0.28 (0.04-2.03)
TT CC 0 0 ---------
Subjects of Punjabi Ethnicity
C677T A1298C Controls (73) PCAG (61) OR (95%CI) p (χ2) p (χ2)
CC AA 3 (4%) 17 (28%) 0.11 (0.03-0.38) 0.001 (17.5) <0.001 (49.6)
CC AC 33 (45%) 27 (44%) 1.04 (0.53-2.05)
CC CC 12 (17%) 2 (3%) 5.80 (1.38-24.03)
CT AA 0 5 (8%) 0.00 (0.00-0.61) <0.001(21.4)
CT AC 20 (27%) 2 (3%) 11.13 (2.74-44.64)
CT CC 5 (7%) 0 ----------
TT AA 0 4 (7%) 0.00(0.00-0.77) N/A
TT AC 0 4 (7%) 0.00(0.00-0.77)
TT CC 0 0 ----------
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a very strong association with PCAG, which is probably due
to the presence of the TT genotype in the disease cohort and
its complete absence from the control population (Table 1).
When the samples were analyzed along ethnic lines, the
Pathans did not show any of the genotypes to be associated
with POAG or PCAG, but the Punjabis showed a highly
significant association of PCAG with the genotypes. In the
Punjabis, both the genotypes containing the mutant alleles, i.e.
CT and TT, were found to be significantly associated with the
disease, the former because it was present at a much lower
frequency in the affected individuals and the latter because it
was present at a higher frequency. The C677T C>T mutation
causes an alanine>valine amino acid substitution, which
results in a 55–65% loss in enzyme activity especially in
individuals who are homozygous for the mutation (TT), while
in the case of heterozygotes (CT) there is a 25% loss in activity
compared to CC homozygous normal individuals [30,31],
leading to hyperhomocysteinemia. Interestingly, when the
tHcy levels were determined, a significantly higher level was
observed in the PCAG subjects as compared to the POAG
subjects and controls (Figure 1). This elevated tHcy level in
PCAG may be mediated by the increased level of tHcy
observed in the TT genotype samples of these patients (Figure
2). Although tHcy levels in the TT genotype were also higher
in the controls and the POAG samples compared to the other
genotypes, in the case of PCAG these levels were the highest
observed, which correlates very well with the genotypic
association of TT with PCAG.
PCAG patients have characteristic biometric ocular
features, including a shallow anterior chamber, increased
thickness of the lens, and a short axial length. It has been
suggested that extracellular matrix (ECM) remodeling maybe
an important determinant of the short axial length [32].
Evidence has suggested restructuring of the sclera in acute
PCAG [33]. As discussed previously [27], we propose that the
high level of homocysteine found in our PCAG subjects is
contributing to the remodeling of the ECM of the anterior
segment in these patients. Hyperhomocysteinemia has been
shown to be involved in the structural remodeling of
connective tissues [34]. Matrix metalloproteases (MMPs) are
a class of proteases that are involved in tissue remodeling
under certain pathological and physiological conditions [35].
Lui et al. [36] have reported the expression of MMP-9, which
cleaves type IV collagen and is important for the remodeling
of the ECM, to be decreased in the Tenon’s capsule of PCAG
patients. Moreover, Seo et al. [37] have shown differential
expression of MMP-2 in PCAG as compared to POAG.
Recent literature supports the hypothesis that these
differential expressions may be altered by variations in
homocysteine levels. Kundu et al. [38] have reported MMP-2,
MMP-9, and MMP-14 to be affected by homocysteine levels
in the cochlea, and suggest that homocysteine induces matrix
imbalance, structural changes, and oxidative stress via the
extracellular signal-regulated kinase (ERK) signaling
pathway [39]. Therefore, it appears logical that the enhanced
activity of MTHFR results in hyperhomocysteinemia and in
turn may induce differential expression of MMPs leading to
tissue remodeling, thereby contributing to the disease
pathogenesis of these PCAG patients.
When the A1298C mutation was studied in the different
samples, no association was observed with POAG, as the
frequency distribution in the combined subjects or the Pathan
and Punjabi patients was not significantly different from the
controls. This is in agreement with previous studies, which
also did not observe any association of this polymorphism
with POAG [13,15]. However, when the PCAG samples were
compared with the controls, significant differences were
found in the Punjabis but not in the Pathans. The Punjabi
subjects had a significantly higher normal AA genotype and
lower homozygous CC frequency in PCAG as compared to
the controls. These results are surprising and indicate a
protective role for MTHFR A1298C mutant alleles in PCAG
patients. Although PCAG is primarily an anatomical defect,
recent evidence suggests that oxidative stress may play a role
in the pathogenesis of PCAG [40]. Decreased activity of the
MTHFR leads not only to increased levels of plasma
homocysteine, as reported here, but simultaneously to
increased DNA synthesis. In this case, there is a possibility
that there is an increased DNA synthesis in PCAG patients
with the MTHFR A1298C polymorphism, that may produce
a counter effect on oxidative-stress-induced DNA damage.
Our combined genotype data also does not reveal any
association of the different combinations with POAG, either
in the combined subjects or in the Punjabi and Pathan ethnic
groups. We also did not find a single double homozygous
mutant (TT/CC) in any of the controls or disease samples. This
is in accordance with previous reports in which it has been
suggested that both mutations cannot be simultaneously
associated with glaucoma because both polymorphisms
always occur in the trans form and not in the cis configuration
[31]. A very strong association of the combined genotypes,
particularly those containing the TT alleles of the C677T
locus, was found with PCAG. When we separated the
combined genotypes along the line of ethnicity, here again,
only the Punjabis showed a very strong association of TT/AA
and TT/AC with PCAG. A limitation of the study was that we
were not able to compare the TT/AA combined genotype as
there were no controls and POAG samples in this group, and
so it is not possible to state whether the high levels of tHcy in
the PCAG was a result of the TT genotype alone or due to the
combined effect of TT/AC genotypes. It has been suggested
that the A1298C polymorphism alone does not significantly
affect tHcy, but does so with the combination of the 677T
variant [41]. It is worth pointing out that in the Punjabis there
was an unexpectedly higher frequency of the CCAA
combination in the PCAG group as compared to the controls
(Table 4), and even when compared with the Punjabi POAG
samples (Table 3). This is because of the higher than usual
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frequency of the AA allele in the Punjabi PCAG samples as
compared to either the controls or the Pathan samples (Table
2), which could be a result of the sample size or some other
factor yet to be identified, but is definitely not a result of higher
tHcy levels in this genotype.
This study is the first to report an association of the TT
genotype, TT/AC combined genotypes, and high tHcy levels
with PCAG. Although correlations of high homocysteine
levels with the TT genotype and the TT/AC combination of
MTHFR have also been reported in other diseases [31,41,
42], we found the levels of tHcy to be much higher in PCAG.
We suggest that this individual or combined genotype may
not be sufficient to account for such high levels of tHcy in the
PCAG subjects, as tHcy levels have been known to be
dependent not only on MTHFR mutations but also on other
factors, such as folate and vitamin B12 status [22,43].
Moreover, the nicotinamide N-methyltransferase gene has
been reported to be the major genetic determinant of plasma
homocysteine levels [43]. The high tHcy levels observed in
this study may, however, be used as an early diagnostic
biomarker for PCAG following required prospective studies.
The present investigation also provides evidence of the
importance of conducting such studies in different ethnic
groups, as even in closely living populations such as the
Pathans and Punjabis, there is clearly a difference in
frequencies of genotypes and combined genotypes leading to
different associations with disease.
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